Top Bristol-Myers shareholder comes out against $74 billion Celgene deal

Bristol-Myers Squibb Co's top shareholder Wellington Management said on Wednesday it does not support the U.S. drugmaker's $74 billion deal to buy biotech Celgene Corp, imperiling what would be the largest pharmaceutical acquisition of all time.


from RSSMix.com Mix ID 8260657 https://ift.tt/2NykZZc

Comments

Post a Comment

Popular posts from this blog

Cards replace Yanks as White Sox opponent at Field of Dreams

The St. Louis Cardinals have replaced the New York Yankees as the opponent for the Chicago White Sox in the Field of Dreams game on Aug. 13 at Dyersville, Iowa. The schedule change caused by the new coronavirus pandemic meant the White Sox no longer play the Yankees this season. The new opponent, first reported by The Des Moines Register, was confirmed to The Associated Press by a person familiar with the arrangements who spoke on condition of anonymity Wednesday because the matchup has not been announced. from RSSMix.com Mix ID 8260652 https://ift.tt/3ipcheH
Read more